FERAHEME comes in single-dose vials (510 mg elemental iron in 17 mL) Administer as an IV infusion over at least 15 minutes when the patient is in a reclined or semi-reclined position Closely observe patients for signs or symptoms of hypersensitivity reactions, including monitoring of blood ...
rather than as anMRI contrast agent. Approval from the United States Food and Drug Administration (FDA) was granted in 2009 for the anaemia indication. This indication called for a 510-mg bolus of Feraheme to be injected in 17 seconds with the potential for a second dose 3–8 days later....
Feraheme 可干扰 MR 诊断 ,应在 给药 前行 MR 检查 , 如必须在 给药之后 3 个月 内行 MR 检查 ,建 议使 用 Tl 或质 子密度加权 MR 使该 药的影响最小化 。 9 小结 慢性 肾病铁静脉用补充剂存在着使用不便 ,不 良反应多 的缺点 ,本品为唯一可供静 脉推注 的铁剂 ,是壳 聚糖包 裹的 ...
Adverse Reactions FERAHEME2 x 510 mg(n=605)%Oral Iron (n=280)% Nausea 3.1 7.5 Dizziness 2.6 1.8 Hypotension 2.5 0.4 Peripheral Edema 2.0 3.2 Headache 1.8 2.1 Edema 1.5 1.4 Vomiting 1.5 5.0 Abdominal Pain 1.3 1.4 Chest Pain 1.3 0.7 Cough 1.3 1.4 Pruritus 1.2 0.4 Pyrexia 1.0 0.7 Back Pa...
Feraheme is indicated for the treatment ofiron deficiency anemia(IDA) in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have chronic kidney disease (CKD). Dosage for Feraheme The recommended dose of Feraheme is an initial 510 mg dose ...
竞价结果: 采购项:Ferumoxytol (Feraheme) Intravenous Solution (纳米氧化铁注射液) 数量:3.0支 品牌: Feraheme 型号: 59338-775-01 单项预算:0.00 成交总价:33066.00 成交单价:11022.00 成交供应商:奥卡斯(宿迁)医药有限公司 质保及售后服务: 技术参数: 510 mg/17 mL (30mg/ml) ...
On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Feraheme™ injection, AMAG Pharmaceuticals), an iron-containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD)...
OBJECTIVE: Ferumoxytol (Feraheme) is a new i.v. iron product recently approved for use in treatment of IDA in CKD patients. This article reviews the structure, pharmacokinetics, and clinical trial results on ferumoxytol. The author also offers his opinions on the role of this product in ...
The recommended dose of FERAHEME is an initial 510 mg dose followed by a second 510 mg dose as early as 3 days and up to 8 days later, each dose infused over at least 15 minutes while the patient is in a reclined or semi-reclined position. ...